OMRON Healthcare Co., Ltd. has revealed further investment in the India-focused AI medtech startup TRICOG HEALTH INDIA PRIVATE LIMITED
Sanofi’s type?1 diabetes therapy Teizeild (teplizumab) has been recommended for approval by the European Medicines Agency’s Committee for Medicinal Products for Human Use. This makes Teizeild the first disease-modifying therapy to type 1 diabetes...
Danish pharmaceutical company Novo Nordisk (NOVOb.CO), opens new tab announced on Tuesday that it has reduced the price of its weight-loss medication, Wegovy, by as much as 37% from its initial launch price in India, as it aims to strengthen
Zydus Lifesciences has been granted consent by the National Medical Products Administration (NMPA) of China on its generic form of Venlafaxine Extended-Release capsules that is applied in the treatment of depressive and anxiety disorders...
Torrent Pharmaceuticals, the flagship company of the Torrent Group, Ahmedabad, is leading its next phase of growth through innovative chronic therapies and expansion in the emerging areas with high growth such as weight loss treatments.
The Oncology Subject Expert Committee (SEC), which is a part of the Central Drugs Standard Control Organisation (CDSCO), has advised that MSN Laboratories Pvt. Ltd. be given the green light to produce and sell Abiraterone Acetate
The U.S. Food and Drug Administration (FDA) has granted final approval to Alembic Pharmaceuticals Limited for its Abbreviated New Drug Application (ANDA) of Sumatriptan Injection which represents a major achievement for the company in the...
Biocon Ltd. informed that its Active Pharmaceutical Ingredient (API) manufacturing facility in Visakhapatnam, Andhra Pradesh
Zydus Lifesciences receives tentative USFDA approval for Olaparib Tablets (100mg, 150mg) used in treating BRCA-related ovarian, breast, pancreatic, and prostate cancers.
Zydus Lifesciences Ltd. is set to broaden its US specialty sector with non-core molecules composition Saroglitazar. The company has a plan to use the funds from its recently approved ?5,000-crore Qualified Institutional Placement